184
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Ocular Pharmacokinetic Study Following Single and Multiple Azithromycin Administrations in Pigmented Rabbits

, &
Pages 149-158 | Received 12 Jan 2007, Accepted 07 Nov 2007, Published online: 02 Jul 2009
 

Abstract

Purpose: The aim of this study was to investigate whether the ocular pharmacokinetic parameters observed following systemic administration are also seen following topical administration. Methods: Azithromycin concentrations were measured by HPLC-MS in pigmented rabbits' tears, cornea, bulbar conjunctiva, and aqueous humor following single instillation and twice-daily instillations for three consecutive days of topical 1.50% azithromycin dihydrate solution. Results: Following a single administration, azithromycin levels were higher than the MIC 4 μ g/g breakpoint for susceptible germs for at least 4 hr in tears, 1 hr in conjunctiva, and 1 hr in cornea after instillation. Following multiple administrations, azithromycin levels were higher than the MIC 4 μ g/g for at least 16 hr in tears, 24 hr in conjunctivae, and 1 week in cornea after the last instillation. Conclusions: Both dosage regimens resulted in adequate and long-lasting azithromycin levels in the conjunctiva, the ocular target tissue relative to the expected therapeutic indication in man (bacterial conjunctivitis), and also in the cornea and tears.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.